http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-1768669-A1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_a499effa2992e3750e1d3a421301c58c |
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y02A50-30 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-455 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P33-02 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P33-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-455 |
| filingDate | 2005-07-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9bd4b803b37fe58cd82b043c7c8a8f0f http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_88dc8cd02207b71d999bed9786177cea http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e7996dfb5c3c63a0beeef9f8d854c4c5 |
| publicationDate | 2007-04-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | EP-1768669-A1 |
| titleOfInvention | Pharmaceutical compositions for the treatment of leishmaniasis |
| abstract | The present invention relates to the use of at least one compound of the following general formula (I): wherein R represents OH or NH2, or of precursors or derivatives thereof, or of the pharmaceutically acceptable salts of said compound or of its precursors or derivatives, for the manufacture of a medicament intended for the prevention or the treatment of parasitic diseases, in particular of protozoan parasitic diseases, more particularly of leishmaniosis, and especially for the prevention or the treatment of parasitic diseases occurring in immunodepressed patients. |
| priorityDate | 2004-07-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 154.